Child pages
  • NCI-MICCAI 2013 Grand Challenges in Image Segmentation

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Summary

Section
Column
width60%
Excerpt
The
Summary: The Cancer Imaging Program of the
National Cancer
Institute
Institute’s (
NCI
NCI’s) Cancer Imaging Program in collaboration with the 16th international conference on Medical Image Computing and Computer Assisted Interventions (MICCAI) 2013
) have
has launched two grand segmentation challenges
in segmentation of
involving clinically relevant prostate structures and brain tumor components based on magnetic resonance imaging (MRI) data. The event will take place at MICCAI 2013 meeting (http://www.miccai2013.org/) on September 22 in Nagoya,Japan.
 

Automated Segmentation of Prostate Structures (ASPS): Magnetic resonance imaging (MRI) is the clinically accepted modality for staging extra capsular extension and thus a key modality for image-guided interventions of the prostate.  The accuracy of such interventions may be improved by automated segmentation of the prostate capsule and clinically relevant internal structures.  The overall goal of the prostate challenge is to promote the development of robust algorithms that automatically segment the neurovascular bundle and seminal vesicles from clinical images. [Due to a low number of registrants at the early registration period, the 2013 prostate challenge is canceled. It will be reconsidered in future.]

Multiparametric Brain Tumor Segmentation (BRATS): Segmentation of brain tumors is a critical step in treatment planning and evaluation of response to therapy.  It It is also one of the most challenging tasks in medical image analysis , due to the variable shape and heterogeneity of such tumors. Magnetic resonance imaging ( MRI ) provides a rich and diverse data set to study brain tumors.  Multicenter Multicenter data will be used for segmentation of to segment four tumor subregions, while inter-reader agreement agreements from clinicians will be used as a benchmark for comparing the algorithm. Participants can access the challenge program, data, and instructions at: https://www.smir.ch/BRATS/Start2013.

Each challenge will be based on a collection of 60 de-identified clinical cases , with expert annotations.   All data will be hosted on The Cancer Image Archive (TCIA) of the National Cancer Institute, USA.  Initially Initially, the contestants may access 40 training cases with annotations.  Several Several weeks before the meeting, they may upload the segmentation of Leader Board leaderboard cases (10) to allow computation of scores as feedback.   "Leaderboard" is a popular term (borrowed from golf) for a procedure to see how well you are doing on a pre-test set in order to get a sense of your relative competitive rank before submitting to a final test. Contestants will be granted access to the sequestered challenge ( test ) data (10 cases) at the beginning of the workshop.  In In the first half of the workshop, participants process the data and report their scores.  Testing Testing of open and closed source solutions will be run in parallel.  In In the second half of the workshop, the scores are posted and presentations are given. 

Please check this wiki in May for further details

Email questions to: imaging.challenge@nih.gov.

Challenge Structure and Time Line

  1. May 24: Training data release.
  2. July 15: Challenge Abstracts Due (new extended deadline).  Free formatted, 2-4 page documents describing approach, preliminary results and conclusions, based on training data.  Acceptance notification will be sent by July 18.  Abstract should be submitted to imaging.challenge@nih.gov.
  3. July 22: MICCAI Early registration deadline.
  4. August 23: Leader Board release (scoring begins Aug 30).
  5. September 22: On-site NCI-MICCAI Challenges: BRATS & ASPS.
Column

Image Added

Panel

Organizers & Major Contributors

Stephen Aylward, Kitware Inc. (stephen.aylward@kitware.com)
Nicholas Nicolas Bloch, Boston University (nicolas.bloch@me.com)
Larry Clarke, NCI (lclarke@mail.nih.gov)
Andinet Enquobahrie, Kitware Inc. (andinet.enqu@kitware.com)
Keyvan Farahani, NCI (Farahani@nih.gov)
John Freymann, SAIC-Frederick (freymanj@mail.nih.gov)
Elizabeth Gerstner, MGH/Harvard Medical School (egerstner@partners.org)
Henkjan Huisman, Radboud University (h.huisman@rad.umcn.nl)
Carl Jaffe, Boston University (carljaffe@gmail.com)
Jayashree Kalpathy-Cramer, Harvard Medical School (kalpathy@nmr.mgh.harvard.edu)
Justin Kirby, SAIC-Frederick (kirbyju@mail.nih.gov)
Anant Madabhushi, Case Western Reserve University (anant.madabhushi@case.edu)
Justin Kirby, SAIC-Fredrick (kirbyju@mail.nih.gov)
Bjoern Menze, ETH Zurich (bjoern@ethz.ch)
Mauricio Reyes, University of Bern (mauricio.reyes@istb.unibe.ch)
Mirabela Rusu, Case Western Reserve University (mirabela.rusu@case.edu)